Follow

This is big news:

"Word came this morning that Biogen is dropping their anti-amyloid antibody (Aduhelm, aducanumab), so it's time to take stock. I was never happy about the FDA's decision to approve it, and that's putting it lightly."

science.org/content/blog-post/

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.